GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Microbot Medical Inc.
Microbot Medical is a company developing miniature robots for performing intravascular surgical procedures. Its stock price is a highly speculative bet on revolutionary technology. The stock price reflects high volatility and dependence on laboratory news.
Share prices of companies in the market segment - Medical instruments
Microbot Medical Inc. develops miniature robots for minimally invasive intravascular surgical procedures. We classify it as a "Medical Instruments" company because it is at the forefront of robotic surgery. The graph below shows the dynamics of this high-tech and capital-intensive medical sector.
Broad Market Index - GURU.Markets
Microbot Medical is an Israeli medical company developing microrobotic devices for minimally invasive surgical procedures. It is a component of the GURU.Markets index, representing the medical robotics sector. The chart below represents the US market. See how this company's stock compares to the US market.
Change in the price of a company, segment, and market as a whole per day
MBOT - Daily change in the company's share price Microbot Medical Inc.
The volatility of Microbot Medical, a developer of medical microrobots, is measured by change_co. It reflects sensitivity to news about developments and trials. This metric is a key component in formulas on System.GURU.Markets for analyzing innovative medical technologies.
Daily change in the price of a set of shares in a market segment - Medical instruments
Microbot Medical Inc. is a company in the medical robotics sector. This chart shows extreme volatility. A comparison with MBOT's performance, with its unique developments, helps to assess it as a high-risk asset dependent on clinical data.
Daily change in the price of a broad market stock, index - GURU.Markets
Microbot Medical develops miniature robots for performing medical procedures inside the body. It's a science fiction company that's become reality. Its shares are extremely volatile, reflecting the high hopes and risks associated with breakthrough technologies, influencing the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Microbot Medical Inc.
Microbot Medical Inc.'s year-over-year performance is a story about the development of miniature medical robots. Its 12-month market cap depends entirely on progress in preclinical and clinical trials of its robotic systems for neurosurgery and vascular procedures. Every successful step is fundamental to validating its futuristic concept.
Annual dynamics of market capitalization of the market segment - Medical instruments
Microbot Medical Inc. is an early-stage medical device company developing miniature robots for performing surgical procedures inside the body. Its stock price is entirely speculative and based on investor confidence in its futuristic technology, not current financial results.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Microbot Medical, which develops microrobots for surgery, is a highly speculative stock. Its performance isn't tied to economic cycles, but rather depends on its ability to prove the viability of its futuristic technology. Its chart is a tale of hope and disappointment, typical of medical robotics startups.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Microbot Medical Inc.
Microbot Medical is at the forefront of medical robotics, but is still in the development stage. Therefore, its monthly market cap reflects expectations. Successful lab tests, progress toward FDA approval, or patent news generate optimism, while the need for new funding can put pressure on the stock.
Monthly dynamics of market capitalization of the market segment - Medical instruments
This chart reflects the dynamics of the nascent medical robotics sector. For Microbot, one of the innovators, it's the backdrop. Its volatile movements reflect not current revenue, but investor expectations related to progress in this complex and promising technology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Microbot Medical develops miniature robots for performing minimally invasive medical procedures inside the body. This is a futuristic but high-risk technology. The overall market chart provides only the background; Microbot shares are driven by news of technological breakthroughs, and their volatility can be extreme, defying overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Microbot Medical Inc.
Microbot Medical Inc. develops miniature robots for use in medical procedures. Its weekly stock price is highly speculative and depends on news about preclinical and clinical trials of its futuristic technology.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive surgical procedures. It sounds like science fiction, and the company's stock reflects hopes for a future revolution in medicine. The chart will show how out of touch its performance is with the rest of the medical equipment sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Microbot Medical develops miniature medical robots. This is a venture-backed technology story straight out of science fiction. The chart will highlight its speculative nature and high volatility compared to a stable market, reflecting faith in the technology.
Market capitalization of the company, segment and market as a whole
MBOT - Market capitalization of the company Microbot Medical Inc.
Microbot Medical's market capitalization is a speculative bet on the future of microrobotics in medicine. Its volatile price chart reflects how investors value its platform for creating miniature robots that can navigate blood vessels. The valuation is based solely on technological potential, not revenue.
MBOT - Share of the company's market capitalization Microbot Medical Inc. within the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside the body. Its market share currently only reflects the potential of this futuristic technology. The chart is a venture capital bet that the company will revolutionize surgery.
Market capitalization of the market segment - Medical instruments
The chart below shows the market capitalization of the medical device sector. Microbot Medical is a company developing miniature robots for performing procedures inside blood vessels. The dynamics of this market reflect the future of surgery. Microbot is a very risky, but potentially revolutionary, bet on the reality of microrobots.
Market capitalization of all companies included in a broad market index - GURU.Markets
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside the body. Its speculative market cap is a bet on the future of microrobotics in medicine. The chart below shows the value of this futuristic idea.
Book value capitalization of the company, segment and market as a whole
MBOT - Book value capitalization of the company Microbot Medical Inc.
Microbot Medical's book value is its equity and the intellectual property it owns for its miniature robots for minimally invasive intravascular surgical procedures. The chart represents the company's preclinical stage, which is investing in the development of its futuristic technology, building an intangible foundation.
MBOT - Share of the company's book capitalization Microbot Medical Inc. within the market segment - Medical instruments
Microbot Medical develops miniature surgical robots. The chart shows its share of actual R&D assets. These are its laboratories where they create devices capable of navigating blood vessels, which are the physical foundation for a new generation of medicine.
Market segment balance sheet capitalization - Medical instruments
Microbot Medical, which develops microrobots, has a lightweight, R&D-focused model. The chart below shows the capital intensity of the medical equipment sector, highlighting its knowledge-intensive business model.
Book value of all companies included in the broad market index - GURU.Markets
Microbot Medical develops miniature robots for performing procedures inside blood vessels. The company's core assets are its R&D. A very small stake in BCap_All provides the financial backing for a futuristic technology that could revolutionize minimally invasive surgery.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Microbot Medical Inc.
Microbot Medical is a medical technology company. Its entire market capitalization is a premium to its cash flow, which is a bet on its futuristic technology for creating microrobots that work inside blood vessels.
Market to book capitalization ratio in a market segment - Medical instruments
Microbot Medical develops miniature robots for medical procedures. Its value lies in its futuristic technology. The chart shows the huge premium investors are paying for the potential of its developments to transform surgery, rather than for its current tangible assets.
Market to book capitalization ratio for the market as a whole
Microbot Medical develops miniature robots for intravascular procedures. It's a futuristic medical technology. This chart clearly demonstrates the premium investors are willing to pay for this vision of the future of medicine, completely ignoring the company's current book value and focusing on its potential.
Debts of the company, segment and market as a whole
MBOT - Company debts Microbot Medical Inc.
Microbot Medical, a company developing miniature robots for medical use, is raising capital to finance its futuristic R&D projects. The debt leverage reflects the cost of preclinical and clinical studies needed to prove the safety and efficacy of its robotic systems before launching them on the market.
Market segment debts - Medical instruments
Microbot Medical develops miniature robots for use inside blood vessels. It sounds like science fiction, but it requires massive, real-world investment in R&D. This chart shows how the company funds its futuristic, yet extremely expensive, developments at the forefront of medical robotics.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Microbot Medical Inc.
Microbot Medical develops miniature robots for use inside blood vessels. This is a futuristic and extremely expensive area of R&D. This chart shows the company's reliance on debt to finance its unique developments. This is a key indicator of its financial risk and ability to bring the technology to market.
Market segment debt to market segment book capitalization - Medical instruments
Microbot Medical develops miniature robots for minimally invasive surgical procedures. This chart shows debt trends in the medical instrument sector. For a company in the development stage, this allows it to evaluate how it finances its advanced and risky technologies and how its financial model compares to other innovators in medical robotics.
Debt to book value of all companies in the market
Microbot Medical develops miniature robots for medical applications, such as vascular cleaning. This cutting-edge technology is currently in the development and testing phase. This graph of the economy's overall debt burden stands in stark contrast to Microbot's financial model. The company relies entirely on shareholders' equity, not on investors' faith in its technology.
P/E of the company, segment and market as a whole
P/E - Microbot Medical Inc.
Microbot Medical develops miniature robots for use in minimally invasive surgery. This chart reflects investors' speculative expectations for its futuristic technology. The company's valuation is a bet on the potential of its microrobots to revolutionize medicine, not on its current financial performance.
P/E of the market segment - Medical instruments
This industry chart for medical device developers is a benchmark for Microbot Medical. It reflects the generally high valuations that investors assign to innovative medtech companies. Comparisons with it help understand how the market values Microbot's futuristic microrobotics technology for medicine and whether it believes in its long-term commercial potential.
P/E of the market as a whole
Microbot Medical is developing miniature robots for use in minimally invasive surgery. This futuristic technology is in the very early stages of development. This graph of investors' overall risk appetite shows how willing they are to invest in science fiction that may only become a medical reality many years from now.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Microbot Medical Inc.
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside the human body. This graph shows speculative expectations for the future of microrobotics in medicine. The estimate depends entirely on technological progress, successful preclinical and clinical trials, and faith in the potential of this futuristic technology.
%20P%2FE%20Microbot%20Medical%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Microbot-Medical-Inc.&v=1772593711801 "Chart of the company's future (projected) P/E Microbot Medical Inc.")
Future (projected) P/E of the market segment - Medical instruments
Microbot Medical develops robotic medical devices for minimally invasive surgical procedures. This chart reflects investor expectations for the company's profitability relative to the sector. It provides an insight into the market's confidence in its technology and its potential to change standards in endovascular surgery.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772593711856 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside the body. For a company at the forefront of medical technology, this market risk appetite curve is vital. Raising the massive capital needed for research and regulatory approvals directly depends on investor confidence in their futuristic technology.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772593711868 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Microbot Medical Inc.
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside blood vessels. This chart shows the company's financial status during the development phase of its futuristic medical technology.
Profit of companies in the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive surgical procedures. This chart shows the profitability of the medical equipment sector. For MBOT, it reflects the future of surgery. Their technology could enable operations inside blood vessels and body cavities with unprecedented precision.
Overall market profit
Microbot Medical develops miniature robots for use inside blood vessels and other cavities in the human body. This futuristic technology has the potential to revolutionize surgery. The company is in the R&D stage. Its valuation is based on the technology's potential. This graph does not reflect the risks and opportunities in the field of medical robotics.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Microbot Medical Inc.
Microbot Medical develops miniature robots for performing minimally invasive surgical procedures inside the body. The revenue projections presented here are highly speculative and reflect expectations for the success of its unique technology. Obtaining regulatory approval is a key step toward commercialization.
%20profit%20of%20the%20company%20Microbot%20Medical%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Microbot-Medical-Inc.&v=1772593711931 "Graph of future (projected) profit of the company Microbot Medical Inc.")
Future (predicted) profit of companies in the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive surgical procedures inside the body. The profit forecast for this futuristic sector depends on technological breakthroughs and regulatory approval. This chart reflects analysts' confidence in the long-term potential of microrobotics in medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772593711945 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Microbot Medical develops microscopic robotic medical devices for minimally invasive procedures. It is a development-stage company. The market profit forecasts shown here reflect the overall risk appetite of investors and their willingness to fund revolutionary medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772593711958 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Microbot Medical Inc.
Microbot Medical develops miniature robots for minimally invasive surgical procedures. This chart shows the company's high speculative valuation at the development stage. Investors are betting on its futuristic technology and potential to revolutionize surgery, evaluating future prospects rather than current revenue.
P/S market segment - Medical instruments
Microbot Medical develops miniature robots for performing minimally invasive surgical procedures inside the human body. This futuristic technology is at the intersection of medicine and robotics. This chart shows the average revenue estimate for the sector, which helps us understand the enormous expectations investors have for Microbot's breakthrough technology.
P/S of the market as a whole
Microbot Medical develops miniature robots for minimally invasive intravascular surgical procedures. The company is in the development and preclinical trials stages. This chart provides a general market backdrop for assessing investor sentiment toward high-risk, yet potentially disruptive, medical technologies of the future.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Microbot Medical Inc.
Microbot Medical develops miniature robots for performing minimally invasive medical procedures inside the human body. This chart shows how the market values the company based on its future revenue potential. It reflects hopes for a revolution in surgery and interventional medicine.
%20P%2FS%20Microbot%20Medical%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Microbot-Medical-Inc.&v=1772593712071 "The graph of the company's future (projected) P/S Microbot Medical Inc.")
Future (projected) P/S of the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive medical procedures inside the body. This is a futuristic technology with enormous potential. This chart reflects investors' faith in its breakthrough developments and its potential to create an entirely new market in medical robotics.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772593712092 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Microbot Medical develops miniature robots for use in minimally invasive surgery. This high-tech company is still in the development stage. This market optimism is vital for MBOT. Raising capital for the development and commercialization of such futuristic medical technologies is only possible if investors have faith in the future.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772593712103 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Microbot Medical Inc.
Microbot Medical is at the forefront of medical robotics, developing miniature robots for minimally invasive intravascular surgical procedures. The company is in the preclinical stage and has no revenue. This timeline will determine whether its futuristic technology can achieve commercial success.
Sales of companies in the market segment - Medical instruments
Microbot Medical develops microscopic robotic medical devices. Their goal is to create tiny robots that can navigate the body's blood vessels to perform minimally invasive procedures. While in the preclinical stage, the company has no commercial revenue yet, but is working at the forefront of medical robotics.
Overall market sales
Microbot Medical develops miniature medical robots designed to navigate within blood vessels for diagnostic and therapeutic procedures. The company operates at the forefront of medical technology. This total revenue chart includes the healthcare sector, where MBOT aims to revolutionize minimally invasive surgery.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Microbot Medical Inc.
Microbot Medical is developing miniature robots for use inside blood vessels, which could revolutionize minimally invasive surgery. This graph reflects analysts' highly speculative expectations for the success of this futuristic medical technology.
%20sales%20of%20the%20company%20Microbot%20Medical%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Microbot-Medical-Inc.&v=1772593712152 "Schedule of future (projected) sales of the company Microbot Medical Inc.")
Future (projected) sales of companies in the market segment - Medical instruments
Microbot Medical develops miniature robots for performing minimally invasive surgical procedures inside the human body. This chart shows forecasts for the advanced medical robotics market. It illustrates the expected development of technologies that can make complex surgeries more precise, safer, and more accessible.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772593712183 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Microbot Medical, a developer of miniature medical robots, sees this chart as a reflection of the future of surgery. The stable economic growth predicted here allows investors and hospitals to invest in breakthrough technologies. Microbot robots are designed for minimally invasive procedures inside blood vessels and body cavities.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772593712195 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Microbot Medical Inc.
Microbot Medical develops robotic medical devices for minimally invasive surgical procedures. While in the development stage, the company incurs significant research and development expenses. This chart does not represent current revenue, but rather the investment required to develop and commercialize its innovative robotic systems.
Market segment marginality - Medical instruments
Microbot Medical develops robotic medical devices for minimally invasive surgical procedures. This chart reflects the potential of its innovative technologies. Future high operating income will confirm that its robots can improve surgical outcomes and are in demand by surgeons.
Market marginality as a whole
Microbot Medical develops miniature robots for medical use. It's an early-stage company, and its valuation is based on the potential of its futuristic technology. This gross profitability chart is unrelated to venture capital risks and the long road to commercialization of medical robots.
Employees in the company, segment and market as a whole
Number of employees in the company Microbot Medical Inc.
Microbot Medical develops miniature medical robots designed to navigate within blood vessels and other body cavities. This graphic shows the small but innovative team working on a technology that could revolutionize minimally invasive surgery and drug delivery.
Share of the company's employees Microbot Medical Inc. within the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive intravascular surgical procedures. This futuristic technology requires an elite team of robotics and micromechanics engineers. This graph illustrates the unique talent required to create the next generation of medical instruments.
Number of employees in the market segment - Medical instruments
Microbot Medical develops miniature robots for minimally invasive intravascular surgical procedures. This graphic shows a team of engineers working at the intersection of robotics and medicine, creating technologies that could revolutionize surgery, making it more precise and safe.
Number of employees in the market as a whole
Microbot Medical Inc. develops microrobotic medical technologies. Their futuristic developments require long-term vision and significant capital. Overall economic stability, reflected by employment trends, is fueling an influx of venture capital investment into breakthrough medical technologies, allowing companies like Microbot to advance science.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Microbot Medical Inc. (MBOT)
Microbot Medical Inc. develops miniature robots for performing procedures inside blood vessels. This chart is like a science fiction valuation for them. The astronomical market capitalization per employee reflects the enormous potential of their platform. The market believes that a small team of engineers is creating the future of surgery.
%20of%20the%20company%20Microbot%20Medical%20Inc.%20(MBOT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Microbot-Medical-Inc.-MBOT&v=1772593712321 "Chart of market capitalization per employee (in thousands of dollars) of the company Microbot Medical Inc. (MBOT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Microbot Medical develops robotic medical devices for minimally invasive procedures. It is a high-tech company whose market capitalization is based on its innovative developments and patents. This chart shows how highly the market values its intellectual capital per employee compared to other medical technology startups.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772593712372 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Microbot Medical develops miniature robots for use inside blood vessels and other body cavities. In this futuristic field of medicine, this figure reflects the enormous potential of its technology. The high employee rating reflects the company's bet that its microrobots will radically transform surgery and drug delivery.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772593712401 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Microbot Medical Inc. (MBOT)
Microbot Medical is a preclinical company developing microrobots for intravascular use. This graph is negative. The company is purely R&D. Its entire staff of engineers and scientists is spending investor capital on creating futuristic medical technology. There is no profit yet.
%20Chart%20Microbot%20Medical%20Inc.%20(MBOT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Microbot-Medical-Inc.-MBOT&v=1772593712414 "Company Profit Per Employee (in thousands of dollars) Chart Microbot Medical Inc. (MBOT)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Microbot Medical (MBOT) is a company developing robotic medical devices for minimally invasive surgery. Their flagship product is a self-cleaning shunt for hydrocephalus. This chart represents an industry benchmark. For the medtech R&D company, it serves as a benchmark, demonstrating the potential profitability the sector aspires to if their innovative robotic systems are successful.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772593712441 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Microbot Medical (MBOT) is an Israeli company developing miniature robots for use inside blood vessels and other body cavities. This is futuristic R&D. This chart doesn't show profit, but rather the investment (R&D costs) per engineer working on this complex microrobotic medical technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772593712463 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Microbot Medical Inc. (MBOT)
Microbot Medical develops miniature robots for minimally invasive surgical procedures. This graph reflects the early stages of development of this breakthrough medical technology. In the future, after approvals, growth in revenue per employee will demonstrate how successfully this futuristic technology is being implemented in real-world clinical practice.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Microbot-Medical-Inc.-MBOT&v=1772593712487 "Sales chart per company employee Microbot Medical Inc. (MBOT)")
Sales per employee in the market segment - Medical instruments
Microbot Medical (MBOT) is developing miniature robots for use inside blood vessels. This is a highly futuristic R&D project in the preclinical stage. They have no revenue. This chart reflects their R&D stage: a staff of engineers but zero sales, which is in stark contrast to the medtech industry average.
Sales per employee for the market as a whole
Microbot Medical is a company from the future. They develop microscopic robots that navigate blood vessels to perform surgeries or deliver drugs. It's purely an R&D business. This graph will likely show zero revenue, as their team of scientists is still in the preclinical stage.
Short shares by company, segment and market as a whole
Shares shorted by company Microbot Medical Inc. (MBOT)
Microbot Medical (MBOT) is a development-stage company creating miniature robots for use inside blood vessels and other body cavities. This chart shows bearish bets. The high short interest reflects deep investor skepticism about this futuristic technology, the enormous regulatory hurdles, and the high capital requirements.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Microbot-Medical-Inc.-MBOT&v=1772593712530 "Short Shares Chart for the Company Microbot Medical Inc. (MBOT)")
Shares shorted by market segment - Medical instruments
Microbot Medical (MBOT) is a company developing robotic medical systems (microrobots) for minimally invasive surgical procedures. This chart reflects the overall sentiment in the medical equipment sector, showing how many investors doubt the technological and financial viability of such futuristic projects.
Shares shorted by the overall market
Microbot Medical (MBOT) develops medical micro-robots. It's one of the most futuristic and speculative stories in medicine. When this general fear indicator rises, investors panic and flee from this "science fiction." Unwilling to wait 10-15 years, they sell MBOT shares to cash out.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Microbot Medical Inc. (MBOT)
Microbot Medical (MBOT) is an Israeli company developing micro-robots for surgery. It's one of the most speculative R&D bets. This chart measures the level of hype. It shows when the euphoria from announcements (overbought) or the despondency from delays (oversold) reach extremes.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Microbot-Medical-Inc.-MBOT&v=1772593712549 "RSI 14 indicator chart for the company's stock Microbot Medical Inc. (MBOT)")
RSI 14 Market Segment - Medical instruments
Microbot Medical is a preclinical medical device company developing miniature robots for use inside the human body (for example, for cleaning shunts or delivering drugs). This chart measures the overall momentum in the medical device sector and helps assess whether this futuristic segment is overheated.
RSI 14 for the overall market
Microbot (MBOT) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MBOT (Microbot Medical Inc.)
Microbot Medical (MBOT) is an Israeli company developing miniature robots for use inside blood vessels and body cavities (e.g., for hydrocephalus). This chart shows the average target price. It reflects analysts' speculative valuations of this futuristic technology and its path to commercialization.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-MBOT-Microbot-Medical-Inc.&v=1772593712551 "A chart showing analyst consensus forecasts for the expected stock price. MBOT (Microbot Medical Inc.)")
The difference between the consensus estimate and the actual stock price MBOT (Microbot Medical Inc.)
Microbot Medical is a futuristic medical technology company developing miniature robots for navigating blood vessels and other body cavities. This chart measures the gap between the current share price and the consensus target price. It highlights the enormous, yet risky, potential analysts see in this sci-fi technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-MBOT-Microbot-Medical-Inc.&v=1772593712553 "A chart showing the difference between the consensus forecast and the actual stock price. MBOT (Microbot Medical Inc.)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Microbot Medical (MBOT) is an Israeli medical company developing miniature robots for performing procedures inside blood vessels. This chart shows analysts' overall expectations for the medical instrument sector. It reflects whether experts believe in the future of "micro-robotic" surgery.
Analysts' consensus forecast for the overall market share price
Microbot Medical is an R&D company working on "micro-robots" for surgery (for example, for cleaning brain shunts). This technology is futuristic, but far from marketable. This chart shows general market sentiment. For MBOT, a "science" startup, it's important to understand how risk appetite (sentiment) affects their ability to fund this "sci-fi" R&D. (348)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Microbot Medical Inc.
Microbot Medical is a biotech company operating on the edge of science fiction. They develop microrobots designed to navigate the human vascular system, for example, to treat strokes or hydrocephalus. This chart is a pure indicator of faith in their futuristic R&D. It doesn't reflect revenue, but rather a speculative estimate of their scientific progress and their chances of success.
AKIMA Market Segment Index - Medical instruments
Microbot Medical develops miniature robots for use inside blood vessels, aiming to transform approaches to treating strokes and aneurysms. This chart shows the average index for the medical instrument sector, allowing one to assess how promising Microbot's futuristic technology is compared to the industry average.
The AKIM Index for the overall market
Microbot Medical is a developer of robotic systems for endovascular surgery (Liberty). Their goal is to democratize robotic surgery. This chart, reflecting the market average, provides context. It helps assess how this pre-commercial MedTech story compares to overall macroeconomic trends and hospital technology adoption.
